0O5H Stock Chart & Stats
kr48.44
kr1.64(3.50%)
At close: 4:00 PM EDT
kr48.44
kr1.64(3.50%)
Day’s Range― - ―
52-Week Rangekr42.20 - kr66.60
Previous CloseN/A
Volume45.70K
Average Volume (3M)955.69K
Market Cap
kr20.94B
Enterprise Valuekr23.05K
Total Cash (Recent Filing)kr2.31B
Total Debt (Recent Filing)kr6.83B
Price to Earnings (P/E)―
Beta1.37
Next Earnings
Nov 25, 2026EPS Estimate
0.83Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.94
Shares Outstanding368,587,650
10 Day Avg. Volume658,271
30 Day Avg. Volume955,692
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.88
Price to Sales (P/S)1.22
P/FCF Ratio8.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr50.18Price Target Upside3.58% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering4
EPS Forecast (FY)3.9
Revenue Forecast (FY)kr17.32B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowImproved free cash flow provides internal funding for product development, service capacity and balance-sheet needs. Sustained cash generation can support resilience even while reported earnings remain under pressure.
Recurring Service And Software RevenueThe installed base creates recurring software, maintenance and upgrade demand alongside equipment sales. This revenue mix can improve visibility and customer retention over time, reducing reliance on individual capital-equipment projects.
Stable Gross MarginA stable gross margin suggests the core offering retains pricing and delivery economics despite weaker revenue. Maintaining this base could support operating recovery if sales volumes and utilization improve.
Bears Say
Sharp Revenue ContractionThe steep revenue decline signals weakened demand, project timing or execution across the business. Prolonged contraction would reduce operating leverage, constrain investment capacity and make recovery in profitability more difficult.
Return To Losses And Lower Operating MarginThe move from solid profitability to a net loss, together with sharply lower EBIT margin, indicates weaker operating leverage or a higher cost base. Restoring sustainable earnings is a key medium-term execution requirement.
Higher Leverage And Shrinking EquityHigher leverage and a shrinking equity base reduce financial flexibility as earnings weaken. This can limit capacity to absorb setbacks or fund strategic investment, despite the company retaining a meaningful absolute equity base.
Elekta AB News
0O5H FAQ
What was Elekta AB’s price range in the past 12 months?
Elekta AB lowest share price was kr42.20 and its highest was kr66.60 in the past 12 months.
What is Elekta AB’s market cap?
Elekta AB’s market cap is kr20.94B.
When is Elekta AB’s upcoming earnings report date?
Elekta AB’s upcoming earnings report date is Nov 25, 2026 which is in 89 days.
How were Elekta AB’s earnings last quarter?
Elekta AB released its earnings results on Aug 27, 2026. The company reported kr0.69 earnings per share for the quarter, beating the consensus estimate of kr0.466 by kr0.224.
Is Elekta AB overvalued?
According to Wall Street analysts Elekta AB’s price is currently Undervalued.
Does Elekta AB pay dividends?
Elekta AB does not currently pay dividends.
What is Elekta AB’s EPS estimate?
Elekta AB’s EPS estimate is 0.83.
How many shares outstanding does Elekta AB have?
Elekta AB has 368,587,650 shares outstanding.
What happened to Elekta AB’s price movement after its last earnings report?
Elekta AB reported an EPS of kr0.69 in its last earnings report, beating expectations of kr0.466. Following the earnings report the stock price went down -6.196%.
Which hedge fund is a major shareholder of Elekta AB?
Currently, no hedge funds are holding shares in GB:0O5H
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Elekta AB
Elekta AB (publ) operates as a global medical technology company, delivering advanced clinical solutions for managing cancer and various brain disorders. Its extensive oncology offerings include sophisticated radiation therapy systems such as Versa HD, tailored for brain metastases; the groundbreaking Elekta Unity, leveraging MR-Linac technology; linear accelerators like Elekta Harmony; and Elekta Infinity, designed to address diverse radiotherapy needs. The company also provides Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy. Beyond primary treatment devices, Elekta supplies comprehensive treatment management solutions, automated and integrated quality assurance tools, and hardware/software for motion management. Specialized oncology platforms feature MOSAIQ Plaza for multidisciplinary cancer care, the managed hosting service Elekta Axis Cloud, and Elekta Studio for image-guided brachytherapy. Complementary hardware includes the ImagingRing mobile CT scanner. For brachytherapy, they offer smart tools like Oncentra Brachy to streamline repetitive tasks, alongside applicators such as Venezia and Geneva for cervical cancer treatment, and the Elekta Flexitron afterloader for precise workflow execution. In the field of neurosurgery and radiosurgery, Elekta provides the Leksell Gamma Knife series, including Icon for personalized radiation treatment, Perfexion as a vital tool for neurosurgeons, and Lightning for accelerated radiosurgery. Their neurosurgery product line further encompasses the Leksell Vantage Stereotactic System for intracranial procedures and the Leksell Stereotactic System for minimally invasive interventions. Elekta AB (publ) was founded in 1972 and is headquartered in Stockholm, Sweden.
0O5H Stock 12 Month Forecast
Average Price Target
kr50.18
▲(3.58% Upside)
Technical Analysis
Stille AB
―
Surgical Science Sweden AB
―
OssDsign AB
―
Corline Biomedical AB
―
FluoGuide A/S
―